Our mission is to lead the epigenetics field in developing high-quality products and services that accelerate chromatin science to improve and extend human life. In this mission, we hold our core values in high regard: mutual respect, fairness, commitment to excellence, customer success, scientific advancement, effective communication, integrity and teamwork.
Advancing Discovery Through Co-Authored Publications
With decades of experience and active collaborations at the forefront of epigenetics research, we bring a unique understanding of the field’s toughest challenges and the solutions to overcome them. Our partnerships span academia, industry, and clinical trials, driving innovation from the lab bench to real-world applications. We love pushing the boundaries of epigenetics and are constantly contributing to move the field forward. Researchers worldwide are leveraging our products and services to accelerate discoveries, and our co-authored publications showcase the impact of these collaborations.
See how our shared passion is shaping the future of epigenetics—explore our latest co-authored publications today!
Featured Technologies
EpiCypher is dedicated to creating novel platforms that support innovative chromatin research. We are constantly expanding our product lines to provide the latest in quantitative chromatin technology.
Our Thoughts
Check in for the latest in EpiCypher technology, chromatin research, and conference news!
- Stuart P. Atkinson
Beyond RNA-seq: Applying CUT&RUN to Decode Drug Resistance and Inform Rational Combination Therapies Key Takeaways: RNA-seq and ATAC-seq reveal transcriptional...
- Stuart P. Atkinson
Fiber-seq Provides a More Complete View of the Human Brain Epigenome Fiber-seq: A Solution to Uncover Unmapped Epigenomic Regions Chromatin...
- Tessa M. Firestone
Interrupting the epigenetic programs that drive tumor growth is a promising avenue for cancer therapy, and NSD2 is emerging as...